MCM
UTHR icon

Matarin Capital Management’s United Therapeutics UTHR Stock Holding History

Matarin Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-3,096
Closed -$348K – 327
2018
Q1 		$348K Hold
3,096
– – 0.03% 265
2017
Q4 		$458K Hold
3,096
– – 0.04% 255
2017
Q3 		$363K Hold
3,096
– – 0.03% 255
2017
Q2 		$402K Hold
3,096
– – 0.04% 233
2017
Q1 		$419K Hold
3,096
– – 0.04% 232
2016
Q4 		$444K Hold
3,096
– – 0.05% 205
2016
Q3 		$366K Hold
3,096
– – 0.04% 204
2016
Q2 		$328K Sell
3,096
-26,206
-89% -$2.92M 0.04% 214
2016
Q1 		$3.27M Buy
29,302
+2,776
+10% +$351K 0.46% 95
2015
Q4 		$4.15M Buy
26,526
+3,136
+13% +$457K 0.62% 73
2015
Q3 		$3.07M Buy
23,390
+5,806
+33% +$931K 0.63% 71
2015
Q2 		$3.06M Buy
17,584
+832
+5% +$150K 0.88% 32
2015
Q1 		$2.89M Buy
16,752
+921
+6% +$140K 0.88% 28
2014
Q4 		$2.05M Sell
15,831
-6,516
-29% -$840K 0.9% 36
2014
Q3 		$2.87M Sell
22,347
-418
-2% -$43.1K 1.32% 4
2014
Q2 		$2.01M Buy
22,765
+3,701
+19% +$356K 0.9% 37
2014
Q1 		$1.79M Sell
19,064
-2,531
-12% -$259K 1.06% 23
2013
Q4 		$2.44M Buy
21,595
+6,305
+41% +$569K 1.5% 9
2013
Q3 		$1.21M Buy
15,290
+2,531
+20% +$185K 1.01% 28
2013
Q2 		$840K Buy
+12,759
New +$822K 0.85% 41

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Matarin Capital Management's UTHR Position: Q2 2018 in Review

Matarin Capital Management sold out of United Therapeutics (UTHR) in Q2 2018, closing a stake of 3,096 shares — an estimated $348K sold.

Matarin Capital Management first reported a position in UTHR in Q2 2013 and held it in 20 quarters. The position peaked at $4.15M in Q4 2015. 374 funds tracked by Wall St. Rank hold UTHR as of Q2 2018.

  • Matarin Capital Management reported no remaining United Therapeutics position as of Q2 2018 after selling out during the quarter.
  • Matarin Capital Management sold 3,096 United Therapeutics shares in Q2 2018, an estimated $348K.
  • Matarin Capital Management first reported a position in United Therapeutics in Q2 2013 and held it in 20 quarters.
  • Matarin Capital Management's United Therapeutics position peaked at $4.15M in Q4 2015.
  • 374 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2018.

Based on Matarin Capital Management's 13F filing for Q2 2018, filed 17 Aug 2018.